Living with diabetes has never been simple, but technology has made daily management far more practical. One of the biggest changes has been the widespread adoption of continuous glucose monitors, or CGMs. Instead of relying on finger sticks multiple times a day, CGMs measure glucose levels in real time and provide around-the-clock data. For many […]

Living with diabetes has never been simple, but technology has made daily management far more practical. One of the biggest changes has been the widespread adoption of continuous glucose monitors, or CGMs.
Instead of relying on finger sticks multiple times a day, CGMs measure glucose levels in real time and provide around-the-clock data. For many people, this is a life-changing upgrade in convenience, accuracy, and peace of mind.
Still, the question remains: How much do continuous glucose monitors cost in 2025? In 2025, the annual cost of continuous glucose monitors can range from 2,000 to 4,500 dollars without insurance, but coverage and assistance programs can dramatically lower that figure.
Understanding how CGMs are priced requires looking at their different components. A CGM system isn’t a single device you buy once and keep for years. It involves disposable and replaceable parts that need to be renewed regularly, which is what makes ongoing costs the biggest concern for most users.
Each CGM includes a sensor, a transmitter, and a display method. The sensor is a tiny piece inserted under the skin, usually on the arm or abdomen, that measures glucose levels. These sensors are disposable and typically last 7 to 14 days, depending on the brand. Because sensors are replaced frequently, they make up the largest recurring expense of CGM ownership.
On average, CGM sensors cost between 40 and 90 dollars each in 2025. That means a person using two to three sensors a month can expect to spend between 1,000 and 2,500 dollars per year just on sensors. The transmitter, which is a small device that attaches to the sensor and sends glucose readings wirelessly, is another expense.
Transmitters last longer than sensors, often around three months, but replacing them costs between 200 and 350 dollars. Finally, the receiver is either a standalone device costing 200 to 400 dollars or, more commonly today, a free smartphone app that displays readings.
When adding everything together, someone paying retail without insurance can expect annual CGM costs to fall between 2,000 and 4,500 dollars. That estimate doesn’t include accessories, adhesive patches, or unexpected replacements, which can push costs higher.
| Component | Function | Replacement Frequency | Typical Cost (USD) | Estimated Annual Cost (USD) |
| Sensor | Measures glucose levels under the skin | Every 7–14 days | $40 – $90 each | $1,000 – $2,500 |
| Transmitter | Sends glucose readings wirelessly to display device | Every 3 months | $200 – $350 each | $800 – $1,400 |
| Receiver / Display | Shows glucose readings (standalone or smartphone app) | Once (device) / App often free | $200 – $400 | $0 – $400 |
| Accessories (optional) | Adhesive patches, protective covers, etc. | As needed | $10 – $50 each | $100 – $300 (variable) |
| Estimated Total Annual Cost (Without Insurance) | $2,000 – $4,500+ |
Insurance is one of the biggest factors in CGM affordability. Private insurance companies in the United States now widely cover CGMs for people with type 1 diabetes and increasingly for people with type 2 diabetes who use insulin.
The details vary, but most insurance plans require prior authorization and documentation from a healthcare provider. After approval, out-of-pocket costs are often reduced to a manageable co-pay.Medicare has also expanded CGM coverage in recent years.
Since 2023, Medicare beneficiaries who use insulin or have a history of hypoglycemia have been eligible. In 2025, Medicare covers 80 percent of the approved CGM cost, leaving patients responsible for 20 percent after meeting their Part B deductible.
For many, that reduces annual spending to around 600 to 1,200 dollars, compared to the thousands paid without coverage.Medicaid coverage is state-dependent. Some states provide CGMs with no cost-sharing, while others limit eligibility to type 1 diabetes patients or require strict documentation. Patients should always check their state’s Medicaid policy before making purchasing decisions.

Employers are also playing a growing role. Wellness programs in 2025 increasingly cover diabetes technology, including CGMs, either fully or through reimbursement. For employees, this can make the difference between using a CGM consistently or going without.
With several CGM brands available, costs vary depending on which system you choose. The most popular brands in the United States remain Dexcom and Abbott’s FreeStyle Libre, though alternatives like Medtronic Guardian and Eversense continue to serve smaller groups of users.
Dexcom’s G7 system, launched in 2023, remains the most advanced option for many. It offers real-time glucose readings every five minutes, customizable alerts, and compatibility with insulin pumps.
However, those features come with a higher price tag. Each G7 sensor lasts 10 days and costs around 80 dollars. That adds up to about 240 dollars per month, or 3,000 to 3,500 dollars annually, not counting transmitters or accessories.
For people with insurance, this cost is usually much lower, but without coverage, Dexcom is one of the pricier options.
Abbott’s FreeStyle Libre 3 is the most budget-friendly CGM widely available in the U.S. Sensors last up to 14 days and cost 45 to 60 dollars each, which translates to about 1,200 to 1,600 dollars annually.
While Libre doesn’t have as many advanced features as Dexcom, it still provides continuous monitoring and integrates well with smartphones. Many people prefer Libre because it offers reliable tracking at a fraction of the cost.
Medtronic’s Guardian system is often used in conjunction with its insulin pumps. Costs vary, but sensors typically last a week and cost around 60 dollars each.
With monthly supplies and transmitters, annual costs reach 3,000 dollars or more. Guardian’s advantage is its integration with Medtronic pumps, which some patients find worth the expense.
Eversense takes a different approach. Instead of replacing sensors every week or two, it uses an implantable sensor that lasts up to six months. The sensor requires a short outpatient procedure to insert and remove, which adds to the upfront cost.
However, long-term users may find the annual cost comparable to or even slightly lower than other systems, depending on insurance. Eversense is still less common but appeals to people who want fewer device changes.
| Brand & Model | Sensor Life | Sensor Cost | Estimated Annual Cost (Without Insurance) | Notable Features |
| Dexcom G7 | 10 days | $80 | $3,000–$3,500 | Alerts, pump integration, real-time updates |
| FreeStyle Libre 3 | 14 days | $45–$60 | $1,200–$1,600 | Affordable, smartphone compatible |
| Medtronic Guardian | 7 days | ~$60 | $2,500–$3,000+ | Pump integration, strong alerts |
| Eversense E3 | 180 days | Higher upfront | $2,500–$4,000+ | Implantable sensor, longest wear time |
Choosing between brands often comes down to balancing cost, features, and lifestyle preferences.
The listed costs are averages, but real-world expenses can look different for every patient. Several key factors influence the actual cost of using a CGM in 2025, including insurance, purchasing options, and assistance programs.
One major factor is where you buy the device. Pharmacies, online medical suppliers, and direct-from-manufacturer programs all set their own pricing. Some pharmacies may offer bulk discounts if you buy several months of sensors at once. Others may have higher retail prices but work seamlessly with insurance billing.
Another factor is the presence of manufacturer discounts and assistance programs. Companies like Dexcom and Abbott often provide savings cards for eligible patients, reducing monthly costs by 50 dollars or more. For low-income families, nonprofit organizations sometimes step in to help cover CGM expenses.
Geography also plays a role. Patients in urban areas usually have more supplier options, leading to competitive pricing, while those in rural regions may have fewer choices and higher costs. Additionally, technological improvements can shift prices. For example, when a new CGM model launches, older models often drop in price, creating opportunities for budget-conscious buyers.
Because CGMs represent an ongoing expense, many users look for ways to cut costs without sacrificing health. Practical steps like comparing pharmacy prices, seeking insurance prior authorization, and using manufacturer programs can significantly reduce out-of-pocket costs.
Some patients save money by purchasing CGM supplies through online mail-order pharmacies, which often provide discounts for automatic refills. Others take advantage of employer wellness programs that reimburse part of the cost. For those without insurance, discussing options with a doctor can open doors to samples, coupons, or nonprofit support.
Planning ahead is another cost-saving strategy. Instead of paying for sensors and transmitters month by month, setting aside a monthly budget can spread out the financial impact. Patients who proactively manage their expenses are less likely to run into gaps in CGM use, which helps maintain stable glucose management.
For families managing diabetes, CGM costs are more than just numbers on a page—they are part of the household budget. Treating CGM expenses like essential medication makes it easier to prioritize and plan for them.
Start by reviewing insurance benefits carefully. Many people don’t realize their insurance requires prior authorization for CGMs, which can delay coverage. Getting approval early ensures smooth access to supplies. Comparing pharmacy and supplier prices is another key step, since costs can differ significantly. In some cases, switching suppliers saves hundreds of dollars a year.
Families should also be aware of nonprofit and community health resources. Some clinics partner with manufacturers to provide CGMs at little to no cost for uninsured patients. Community programs focused on chronic illness management may also distribute discounted supplies.
Consider the financial impact beyond direct costs. Using a CGM consistently can reduce emergency room visits, hospitalizations, and long-term complications, ultimately saving money. In this sense, CGMs are not just an expense but an investment in health.

In 2025, continuous glucose monitors remain a significant financial commitment, but they are also more accessible than ever. Out-of-pocket costs can reach 2,000 to 4,500 dollars annually, yet insurance, Medicare, Medicaid, and assistance programs reduce that figure for many users.
Dexcom leads with advanced features at a higher cost, while FreeStyle Libre provides an affordable and reliable alternative. Medtronic and Eversense serve niche users with specialized needs.
For anyone living with diabetes, understanding the true cost of CGMs is essential to budgeting effectively. By taking advantage of insurance coverage, discount programs, and smart purchasing strategies, patients can make this technology part of their daily lives without overwhelming their finances.
The value of better glucose control, improved quality of life, and reduced long-term complications makes CGMs well worth the effort of managing their cost.
